✦ LIBER ✦

Phase II Study of Docetaxel and S-1 (DS) as Neoadjuvant Chemotherapy for Clinical Stage III Resectable Gastric Cancer

✍ Scribed by Oki, Eiji; Emi, Yasunori; Kusumoto, Tetsuya; Sakaguchi, Yoshihisa; Yamamoto, Manabu; Sadanaga, Noriaki; Shimokawa, Mototsugu; Yamanaka, Takeharu; Saeki, Hiroshi; Morita, Masaru; Takahashi, Ikuo; Hirabayashi, Naoki; Sakai, Kenji; Orita, Hiroyuki; Aishima, Shinichi; Kakeji, Yoshihiro; Yamaguchi, Kazuya; Yoshida, Kazuhiro; Baba, Hideo; Maehara, Yoshihiko

Book ID: 125405979
Publisher: Springer
Year: 2014
Tongue: English
Weight: 320 KB
Volume: 21
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-014-3594-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel plus cisplatin as neoadjuvant

Docetaxel plus cisplatin as neoadjuvant chemotherapy for unresectable stage III Non-Small-Cell Lung Cancer (NSCLC): A phase II study

✍ Dediu, M; Horvat, T; Tarlea, A; Nicodin, A; Movanu, M; Radult, M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

A phase II study of neoadjuvant combinat

A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker

✍ Masahiro Hirakawa, Yasushi Sato, Hiroyuki Ohnuma… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 227 KB

Biweekly docetaxel and gemcitabine as ne

Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy in stage II and III breast cancer patients: Preliminary results of a phase II and pharmacogenomic study

✍ Laura G Estévez; Pedro Sánchez-Rovira; Manuel Dómine; A León; Isabel Calvo; Ana 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Phase II study of docetaxel, capecitabin

Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer

✍ Yen-Shen Lu; Dar-Ren Chen; Ling-Min Tseng; Dah-Cherng Yeh; Shou-Tung Chen; Chia- 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 278 KB

Phase II study of biweekly docetaxel and

Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer

✍ Chikara Kunisaki; Masazumi Takahashi; Hirochika Makino; Takashi Oshima; Shoichi 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 272 KB

A phase II study of neoadjuvant docetaxe

A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma

✍ Park, Inkeun; Ryu, Min-Hee; Choi, Yoon Hee; Kang, Hyo Jeong; Yook, Jeong Hwan; P 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 382 KB